AG
Advocate Group’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.37M | Sell |
345,375
-8,297
| -2% | -$201K | 1.5% | 23 |
|
|
2025
Q1 | $8.96M | Buy |
353,672
+12,294
| +4% | +$312K | 1.63% | 20 |
|
|
2024
Q4 | $9.06M | Buy |
341,378
+12,548
| +4% | +$333K | 1.71% | 16 |
|
|
2024
Q3 | $9.52M | Buy |
328,830
+11,989
| +4% | +$347K | 1.73% | 12 |
|
|
2024
Q2 | $8.87M | Buy |
316,841
+21,772
| +7% | +$609K | 1.79% | 14 |
|
|
2024
Q1 | $8.19M | Buy |
295,069
+59,561
| +25% | +$1.65M | 1.63% | 17 |
|
|
2023
Q4 | $6.78M | Buy |
235,508
+10,548
| +5% | +$304K | 1.46% | 23 |
|
|
2023
Q3 | $7.46M | Buy |
224,960
+5,433
| +2% | +$180K | 1.73% | 14 |
|
|
2023
Q2 | $8.05M | Buy |
219,527
+12,315
| +6% | +$452K | 1.77% | 16 |
|
|
2023
Q1 | $8.45M | Buy |
207,212
+9,214
| +5% | +$376K | 1.85% | 15 |
|
|
2022
Q4 | $10.1M | Buy |
197,998
+4,756
| +2% | +$244K | 2.18% | 6 |
|
|
2022
Q3 | $8.46M | Buy |
193,242
+2,007
| +1% | +$87.8K | 2.09% | 10 |
|
|
2022
Q2 | $10M | Buy |
+191,235
| New | +$10M | 2.33% | 7 |
|